Zambon Biotech obtains exclusive European license from Amneal
Cadempino/Bridgewater - Zambon Biotech has obtained an exclusive license to seek regulatory approval for and market a Parkinson’s drug produced by U.S. pharmaceutical company Amneal. The novel oral formulation of an existing medicine is currently being reviewed by the U.S. regulatory authority.
UZH team uncovers cause of post-stroke risk
Zurich - A research group from the University of Zurich (UZH) has discovered that the risk of a cerebral hemorrhage increases in stroke patients whose brains are resupplied with blood too quickly after the blood clot has been removed. This happens when vascular bridges between neighboring arterial trees are blocked.
US firm Datasite agrees deal to acquire Sherpany
Zurich/Minneapolis - Sherpany is being acquired by Datasite. In so doing, the company from Minneapolis is expanding its product portfolio for strategic transaction projects with the addition of Sherpany’s board-level meeting management software.
Squirro enters partnership with Adnovum
Zurich/Zollikon - Squirro and Adnovum from the canton of Zurich are joining forces to develop the next generation of artificial intelligence (AI). Adnovum plans to use Squirro's technology to improve its digital solutions. The goal is to put clients from diverse industries at the forefront of generative AI.
UZH on the case of a cause of dementia
Zurich - A team from the University of Zurich (UZH) has developed an innovative cell culture model for nerve cells. This shows that there is a correlation between a misregulated protein and the degeneration of nerve cells in two types of neurodegenerative disease.
Researchers learn the language of the nervous system
Zurich - Zurich-based researchers working with an international team have discovered that neural prostheses communicate more effectively with the brain via natural signals than with the conventionally used time-constant stimulation of the sciatic nerve. These findings could be used to give amputees greater confidence in their prosthesis.
Agroscope gets the green light to start field trial with gene scissors
Zurich - This spring, Agroscope will launch a field trial with spring barley in which genetic scissors will be used to disable a certain gene. The aim here is to demonstrate whether these mutations lead to an increased yield. The Federal Office for the Environment has approved the experiment on Agroscope's protected site subject to certain conditions.
ETH heads up new chip initiative
Zurich - The Swiss Federal Institute of Technology in Zurich (ETH) is heading up an initiative for the domestic production of chips. The program aims to strengthen Switzerland’s self-sufficiency in the face of competition from the European and US markets.
Solita opens new office in Zurich under its Intellishore brand
Zurich/Copenhagen/Helsinki - Solita, the Finnish data analysis and strategic consulting firm, is opening an office in Zurich under its Danish brand Intellishore. Intellishore specializes in addressing complex data and strategy problems for multinational companies, particularly those operating in the life sciences sector.
Meet with an expansion expert
Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center? Give us a call or drop us a line.